+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic value of lymph node ratio in survival of patients with locally advanced rectal cancer



Prognostic value of lymph node ratio in survival of patients with locally advanced rectal cancer



Canadian Journal of Surgery. Journal Canadien de Chirurgie 58(4): 237-244



The lymph node ratio (LNR) has been shown to be an important prognostic factor in patients with gastric, breast, pancreatic and colorectal cancer. We investigated the prognostic impact of the LNR in addition to TNM classification in patients with locally advanced rectal cancer. We retrospectively analyzed patients who underwent curative resection for locally advanced rectal cancer between July 2005 and December 2010. We determined the LNR cutoff value using a receiver operating characteristic curve. The Kaplan-Meier method was used to estimate survival curves, while Cox regression analyses were used to evaluate the relationship between LNR and survival. We included 180 patients aged 28-83 years with median follow-up of 41.8 months. The median number of lymph nodes examined and lymph nodes involved were 11.5 and 4, respectively, and the median LNR was 0.366. An LNR of 0.19 (19%) was the cutoff point to separate patients with regard to median overall survival. Median overall survival was 64.2 months for patients with an LNR of 0, 59.1 for an LNR of 0.19 or less and 37.6 for an LNR greater than 0.19 (p = 0.004). The median disease-free survival was 32.9 months for patients with an LNR of 0, 30.4 for an LNR of 0.19 or less and 17.8 for an LNR greater than 0.19 (p = 0.002). Our results suggest that LNR should be considered an additional prognostic factor in patients with locally advanced rectal cancer. Il a été démontré que le ratio de ganglions lymphatiques positifs est un important facteur pronostique chez les patients atteints de cancer de l’estomac, de cancer du sein, de cancer du pancréas et de cancer colorectal. Nous avons étudié l’incidence pronostique de l’utilisation de ce ratio en plus de la classification TNM chez les patients présentant un cancer du rectum localement avancé. Nous avons analysé rétrospectivement des patients ayant subi une résection curative visant à traiter un cancer du rectum localement avancé entre juillet 2005 et décembre 2010. Nous avons déterminé la valeur seuil du ratio de ganglions lymphatiques positifs à l’aide d’une courbe caractéristique de la performance. La méthode de Kaplan-Meyer a été utilisée pour estimer les courbes de survie, tandis que le modèle de régression des hasards proportionnels de Cox a servi à évaluer la corrélation entre le ratio à l’étude et la survie. Notre étude a porté sur 180 patients de 28 à 83 ans dont la durée médiane du suivi était de 41,8 mois. Les nombres médians de ganglions lymphatiques examinés et de ganglions lymphatiques positifs étaient de 11,5 et 4, respectivement, et le ratio médian de ganglions lymphatiques positifs était de 0,366. Nous avons utilisé une valeur seuil de 0,19 (19 %) pour séparer les patients en ce qui a trait à la survie globale médiane. Cette mesure était de 64,2 mois pour les patients présentant un ratio de 0, de 59,1 mois pour ceux présentant un ratio de 0,19 ou moins, et de 37,6 mois pour ceux dont le ratio était supérieur à 0,19 (p = 0,004). La survie sans récidive médiane était de 32,9 mois pour les patients présentant un ratio de 0, de 30,4 mois pour ceux présentant un ratio de 0,19 ou moins, et de 17,8 mois pour ceux dont le ratio était supérieur à 0,19 (p = 0,002). Nos résultats indiquent que le ratio de ganglions lymphatiques positifs devrait être envisagé comme facteur pronostique supplémentaire pour les patients atteints d’un cancer du rectum localement avancé.

(PDF emailed within 1 workday: $29.90)

Accession: 058637850

Download citation: RISBibTeXText

PMID: 26022151


Related references

Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision. Medicine 95(9): E2988, 2016

Prognostic value of lymph node ratio in survival of patients with stage III rectal cancer. Zhonghua Zhong Liu Za Zhi 34(7): 506-509, 2013

Prognostic significance of the lymph node ratio regarding recurrence and survival in rectal cancer patients treated with postoperative chemoradiotherapy. Gut and Liver 6(2): 203-209, 2012

The prognostic value of lymph node ratio and updated TNM classification in rectal cancer patients with adequate versus inadequate lymph node dissection. Techniques in Coloproctology 18(9): 805-811, 2015

Prognostic influence of the lymph node yield in locally advanced rectal cancer treated with preoperative radiochemotherapy. Reports of Practical Oncology & RadioTherapy 18: S222-S223, 2013

Coexistence of perineural invasion and lymph node metastases is a poor prognostic factor in patients with locally advanced rectal cancer after preoperative chemoradiotherapy followed by radical resection and adjuvant chemotherapy. Medical Principles and Practice 23(5): 465-470, 2015

Prognostic impact of the metastatic lymph node ratio on survival in rectal cancer. Annals of Coloproctology 29(3): 100-105, 2013

Extraperitoneal lymph node dissection in locally advanced cervical cancer; the prognostic factors associated with survival. Journal of the Turkish German Gynecological Association 18(2): 77-84, 2017

Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer. International Journal of Colorectal Disease 33(4): 367-374, 2018

Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection. Asian Pacific Journal of Cancer Prevention 15(13): 5365-5369, 2015

The prognostic value of lymph node ratio in a national cohort of rectal cancer patients. European Journal of Surgical Oncology 42(4): 504-512, 2016

Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers. Cancer Immunology, ImmunoTherapy 2018, 2018

Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer. World Journal of Surgical Oncology 16(1): 198, 2018

The Prognostic Value of 18F-FDG Uptake in the Supraclavicular Lymph Node (N3c) on PET/CT in Patients With Locally Advanced Breast Cancer With Clinical N3c. Clinical Nuclear Medicine 44(1): E6-E12, 2018

Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation. Journal of Surgical Oncology 104(1): 53-58, 2011